{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:52:47Z","timestamp":1787496767828,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.virusres.2015.07.015","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T15:09:13Z","timestamp":1438787353000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir"],"prefix":"10.1016","volume":"210","author":[{"given":"S.-H. Sheldon","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Agafitei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Liggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Petric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2015.07.015_bib0005","doi-asserted-by":"crossref","first-page":"e1002431","DOI":"10.1371\/journal.ppat.1002431","article-title":"Role of permissive neuraminidase mutations in influenza A\/Brisbane\/59\/2007-like (H1N1) viruses","volume":"7","author":"Abed","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2015.07.015_bib0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/AAC.42.4.801","article-title":"Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140","volume":"42","author":"Bantia","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.07.015_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/viro.1998.9194","article-title":"The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en","volume":"246","author":"Blick","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.07.015_bib0020","doi-asserted-by":"crossref","first-page":"e1004065","DOI":"10.1371\/journal.ppat.1004065","article-title":"Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1) pdm09 influenza viruses","volume":"10","author":"Butler","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2015.07.015_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(01)00215-7","article-title":"Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo","volume":"54","author":"Carr","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virusres.2015.07.015_bib0030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1039\/p19950001173","article-title":"Synthesis of the potent influenza neuraminidase inhibitor 4-guanidino Neu5Ac2en X-ray molecular structure of 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-d-erythro-l-gluco-nononic acid","volume":"1","author":"Chandler","year":"1995","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.virusres.2015.07.015_bib0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2015.07.015_bib0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Oseltamivir-resistance working group, infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.virusres.2015.07.015_bib0045","first-page":"137","article-title":"Interim estimates of 2013-14 seasonal influenza vaccine effectiveness\u2014United States: February 2014","volume":"63","author":"Flannery","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.virusres.2015.07.015_bib0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.coi.2011.07.016","article-title":"The pathogenesis of influenza virus infections: the contributions of virus and host factors","volume":"23","author":"Fukuyama","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-2659.2009.00072.x","article-title":"Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers","volume":"3","author":"Garc\u00eda","year":"2009","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.virusres.2015.07.015_bib0060","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00705-012-1577-3","article-title":"Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice","volume":"158","author":"Gen","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1128\/JVI.06085-11","article-title":"Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses","volume":"86","author":"Ginting","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0070","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania: South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virusres.2015.07.015_bib0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1232552","article-title":"Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virusres.2015.07.015_bib0085","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/JVI.77.15.8418-8425.2003","article-title":"Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors","volume":"77","author":"Matrosovich","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","article-title":"Resistance of influenza viruses to neuraminidase inhibitors-a review","volume":"47","author":"McKimm-Breschkin","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virusres.2015.07.015_bib0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.40.1.40","article-title":"Generation and characterization of variants of NWS\/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en","volume":"40","author":"McKimm-Breschkin","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.07.015_bib0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"European influenza surveillance scheme, oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u201308 season","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.07.015_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2014.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors 2012\u20132013","volume":"110","author":"Meijer","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virusres.2015.07.015_bib0110","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1128\/JVI.76.11.5380-5386.2002","article-title":"In vitro selection and characterization of influenza A (A\/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675","volume":"76","author":"Molla","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2015.07.015_bib0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.antiviral.2011.03.180","article-title":"Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro","volume":"90","author":"Niikura","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virusres.2015.07.015_bib0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3947\/ic.2013.45.4.375","article-title":"Influenza vaccines: unmet needs and recent developments","volume":"45","author":"Noh","year":"2013","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.virusres.2015.07.015_bib0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virusres.2015.07.015_bib0135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1517\/13543784.11.6.859","article-title":"Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza","volume":"11","author":"Sidwell","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.virusres.2015.07.015_bib0140","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/AAC.42.12.3234","article-title":"Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071","volume":"42","author":"Tai","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.07.015_bib0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/JCM.41.2.742-750.2003","article-title":"Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network","volume":"41","author":"Wetherall","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rmv.352","article-title":"Functional balance between haemagglutinin and neuraminidase in influenza virus infections","volume":"12","author":"Wagner","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virusres.2015.07.015_bib0155","first-page":"279","article-title":"Influenza vaccines","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Wkly. Epidemiol. Rec."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215300198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215300198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T22:53:21Z","timestamp":1567032801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170215300198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":31,"alternative-id":["S0168170215300198"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2015.07.015","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2015.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}